Clinical trial
Opposing Step-by-step Insulin Reinforcement to Intensified Strategy
NCT00174642 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00174642 |
|---|---|
| Title | Opposing Step-by-step Insulin Reinforcement to Intensified Strategy |
| Official title | Comparison of Three Therapeutic Strategies for Treating Type 2 Diabetes Mellitus Patients Poorly Controlled With Basal Insulin Associated With Oral Antidiabetic Drugs |
| Acronym | OSIRIS |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Insulin Glargine, Insulin Glulisine, Metformin, insulin secretagogue |
| Enrollment | 811 |
| Start date | Dec 1, 2004 |
| Primary completion | Dec 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Sep 15, 2009 |
| Countries | Belgium, France, Germany, Greece, Hungary, Ireland, Italy, Lithuania, Mexico, Netherlands, Poland, Russia and 6 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: